Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Bregal Unternehmerkapital on its acquisition of Iptor
Mandate

Vinge advises Bregal Unternehmerkapital on its acquisition of Iptor

January 07, 2020 M&A

Vinge has advised Bregal Unternehmerkapital on its acquisition of Iptor from Marlin Equity Partners.

Iptor is a global leader in enterprise resource planning, supply chain management, planning and logistics software and services. Serving 1,250 customers in more than 40 countries, Iptor provides fully integrated enterprise solutions, with highly adaptable and robust software backed by world-class support from distribution and supply chain experts.

Vinge’s team consisted of Christina Kokko, Ulrich Ziche, Carl Sander, Martin Cronsioe, Fredric Reissmüller, Viktor Lennartsson and Karl Klackenberg (M&A), Albert Wållgren and Ludvig Wettergren (Banking and Finance), Jolene Reimerson, Jasmin Draszka, Mika Jordan, Fredrika Hjelmberg, Lisa Hörnqvist and Sofia Landolsi (Commercial Agreements), Jakob Kraus (IP), Lisa Ullman and Sophia Holm (Employment), Karolina Cohrs (Real Estate) and VDR assistants Viktoria Owetz and Christoffer Widström.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025